CA2281524A1 - Anti-microbial product - Google Patents

Anti-microbial product Download PDF

Info

Publication number
CA2281524A1
CA2281524A1 CA002281524A CA2281524A CA2281524A1 CA 2281524 A1 CA2281524 A1 CA 2281524A1 CA 002281524 A CA002281524 A CA 002281524A CA 2281524 A CA2281524 A CA 2281524A CA 2281524 A1 CA2281524 A1 CA 2281524A1
Authority
CA
Canada
Prior art keywords
group
antibiotic
flavonoid
product
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002281524A
Other languages
English (en)
French (fr)
Inventor
Iain Xiaojun Liu
David Garnet Durham
Robert Michael Edward Richards
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BTG International Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9703532.3A external-priority patent/GB9703532D0/en
Application filed by Individual filed Critical Individual
Publication of CA2281524A1 publication Critical patent/CA2281524A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA002281524A 1997-02-20 1998-02-18 Anti-microbial product Abandoned CA2281524A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9703532.3A GB9703532D0 (en) 1997-02-20 1997-02-20 Anti-microbial agent
GB9703532.3 1997-12-12
GB9726401.4 1997-12-12
GBGB9726401.4A GB9726401D0 (en) 1997-02-20 1997-12-12 Anti-Microbial product
PCT/GB1998/000512 WO1998036750A1 (en) 1997-02-20 1998-02-18 Anti-microbial product

Publications (1)

Publication Number Publication Date
CA2281524A1 true CA2281524A1 (en) 1998-08-27

Family

ID=26311033

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002281524A Abandoned CA2281524A1 (en) 1997-02-20 1998-02-18 Anti-microbial product

Country Status (7)

Country Link
EP (1) EP0973523A1 (pt)
JP (1) JP2001512473A (pt)
AU (1) AU726471B2 (pt)
BR (1) BR9807444A (pt)
CA (1) CA2281524A1 (pt)
GB (1) GB9726401D0 (pt)
WO (1) WO1998036750A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6677350B1 (en) * 1999-09-22 2004-01-13 Advanced Life Sciences, Inc. Beta-fluoroethyl thiourea compounds and use
DE10244282A1 (de) * 2002-09-23 2004-04-01 Merck Patent Gmbh Zubereitung mit antioxidanten Eigenschaften
WO2007097940A2 (en) 2006-02-13 2007-08-30 Trustees Of Boston University Reca inhibitors with antibiotic activity, compositions and methods of use
WO2008019292A2 (en) * 2006-08-04 2008-02-14 Trustees Of Boston University Compositions and methods for potentiating antibiotic activity
JP5852007B2 (ja) 2009-12-18 2016-02-03 コルゲート・パーモリブ・カンパニーＣｏｌｇａｔｅ−Ｐａｌｍｏｌｉｖｅ Ｃｏｍｐａｎｙ 抗微生物剤の増進剤としてのカルコン類
CN105732558B (zh) * 2014-12-12 2018-05-15 中国人民解放军第二军医大学 蒿属植物中单体奇蒿黄酮的提取方法及其在制备抑制金黄色葡萄球菌药物中的应用
CN110903272B (zh) * 2019-12-10 2023-02-17 广州医科大学 黄酮类化合物及其制备方法和应用
CN116098914B (zh) * 2023-03-21 2023-10-24 青岛农业大学 一种组合物及防治嗜麦芽窄食单胞菌的药物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3319800B2 (ja) * 1993-02-01 2002-09-03 辻本化学工業株式会社 抗耐性黄色ブドウ球菌化合物

Also Published As

Publication number Publication date
GB9726401D0 (en) 1998-02-11
BR9807444A (pt) 2000-04-25
AU6108198A (en) 1998-09-09
WO1998036750A1 (en) 1998-08-27
EP0973523A1 (en) 2000-01-26
JP2001512473A (ja) 2001-08-21
AU726471B2 (en) 2000-11-09

Similar Documents

Publication Publication Date Title
Liu et al. Baicalin synergy with β‐lactam antibiotics against methicillin‐resistant Staphylococcus aureus and other β‐lactam‐resistant strains of S. aureus
Cushnie et al. Antimicrobial activity of flavonoids
US6294526B1 (en) Use of flavone derivatives for induction of β-lactam-sensitivity of MRSA
Özçelik et al. Antimicrobial activity of flavonoids against extended-spectrum β-lactamase (ESβL)-producing Klebsiella pneumoniae
Dubey et al. Antibacterial activity of Lantana camara L. against multidrug resistant pathogens from ICU patients of a teaching hospital
Akinjogunla et al. Antibacterial activity of ethanolic extracts of Phyllanthus amarus against extended spectrum β-lactamase producing Escherichia coli isolated from stool samples of HIV sero-positive patients with or without diarrhea
KR101401658B1 (ko) 진세노사이드 컴파운드 ｋ 또는 이의 유도체로 된 항균제
JPH09509677A (ja) 茶エキスまたはその活性フラクションおよびβ−ラクタム抗生物質を含む抗菌剤
US20140193530A1 (en) Pharmaceutical composition containing honeysuckle extract and antibiotics, pharmaceutical kit, and use of honeysuckle extract for preparation of drug
Bensizerara et al. Antimicrobial activity of xerophytic plant (Cotula cinerea Delile) extracts against some pathogenic bacteria and fungi
Adu et al. The effects of Acanthospermum hispidum extract on the antibacterial activity of amoxicillin and ciprofloxacin
JP2003171274A (ja) 薬剤耐性菌感染症治療のための医薬組成物および消毒剤
Chusri et al. Synergistic effects of ethnomedicinal plants of Apocynaceae family and antibiotics against clinical isolates of Acinetobacter baumannii
JP2003171274A5 (pt)
Ziad et al. Antibacterial activity of Rheum rhaponticum, Olea europaea, and Viola odorata on ESBL producing clinical isolates of Escherichia coli and Klebsiella pneumoniae
AU726471B2 (en) Anti-microbial product
JP2952767B2 (ja) フラボン誘導体によるメチシリン耐性黄色ブドウ球菌（Ｍｅｔｈｉｃｉｌｌｉｎ−Ｒｅｓｉｓｔａｎｔ Ｓｔａｐｈｙｌｏｃｏｃｃｕｓ ａｕｒｅｕｓ：ＭＲＳＡ）に対するβ−ラクタム剤感受性誘導作用
KR102203849B1 (ko) 동물용 복합 항생제 조성물
WO1993014770A1 (en) Pharmaceutical formulations comprising a clavulanic acid salt and erithromycin derivative
Almutairi Evaluation of the inhibitory activity of some plant extracts against Staphylococcus aureus and Klebsiella pneumoniae clinically isolated from patients with tonsillitis.
Fedorko et al. In vitro activity of coumermycin A1
KR20200030863A (ko) 소포라플라바논 g를 유효성분으로 포함하는 항균 조성물
Okwubie et al. Evaluation of the antimicrobial activity of the crude root extracts of Allamanda cathartica L (Apocynaceae)
MXPA99007686A (es) Producto anti-microbiano
Bodey et al. Pirbenicillin, a new semisynthetic penicillin with broad-spectrum activity

Legal Events

Date Code Title Description
FZDE Dead